Is pSivida Corp. Trending?
According to the aggregate analysts rating, pSivida Corp. (NASDAQ:$PSDV) currently sits at an average rating of ‘Buy’. This rating is determined by analysts who look at a combination of wave theory, momentum, and volatility to ... [Read]
An Analysis of pSivida Corp.
Recently, pSivida Corp. (NASDAQ:$PSDV) has failed to live up to its previous stock prices. The current price stands -1.41% below the 20 day average. While the stock did recover partially over the 50 day moving ... [Read]
pSivida Announces Development of Sustained Release Glaucoma Drug with a Partner Global Pharmaceuticals Company
pSivida Corp (NASDAQ:$PSDV) has announced that it has signed an agreement with a major global pharmaceutical company to develop two new glaucoma drugs using their proprietary sustained release technology. The company is a leading developer ... [Read]
pSivida Corp.: What the Indicators Tell Us
Recently, traders have noticed that pSivida Corp. (NASDAQ:$PSDV) stock has seen its Percentage Price Oscillator Histogram level just under zero. This could indicate it may be time to sell. Another tool for forecasting a stock ... [Read]
Earnings of -$0.15 Per Share Expected from pSivida Corp.
Zacks Investment Research reports that wall street brokerages forecast an EPS of -$0.15 from pSivida Corp. (NASDAQ:$PSDV). The aggregate is based on two analyst issued earnings forecasts. In the same quarter last year, pSivida Corp. ... [Read]